Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for ...
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...
November 7, 2016 — Edwards Lifesciences Corp. recently announced new data demonstrating dramatic and sustained ...
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics ...
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device ...
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
November 7, 2016 — The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3 ...
November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated ...
November 7, 2016 – Two-year results from the COLOR Trial, the first large-scale multicenter prospective study of its ...
November 3, 2016 — Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients ...
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First ...
November 2, 2016 — Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the ...
November 08, 2016